JPRN-UMIN000017791已完成2 期
Phase II trial of gemcitabine monotherapy in the third or further line for pretreated patients with advanced non-small cell lung cancer - OPH-RM-LC-1502
Dept.Repiratory Medicine, Osaka Police Hospital0 个研究点目标入组 21 人开始时间: 2015年6月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) A history of gemcitabine treatment 2) Current or previous history of pulmonary fibrosis, interstitial pneumonitis or drug-induced pneumonia, revealed by chest X-ray film 3) Concurrent thoracic radiotherapy 4) A history of severe hypersensitivity against gemcitabine 5) Another active advanced malignancy that requires any concurrent treatment with treatment for lung cancer 6) Pleural effusion, ascites or peri-cardiac effusion requiring dranage. 7) Problematic complications 8) Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy 9) Decision of ineligibility by a physician
研究者
相似试验
已完成
2 期
Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001)Pancreatic cancerJPRN-UMIN000003658kanagawa cancer center66
未知
2 期
A Phase II multicenter trial of Gemcitabine in combination with R1415 (erlotinibhydrochloride) in patients with unresectable pancreatic cancer (locally advanced or metastatic)Pancreatic cancerJPRN-jRCT2080220332Chugai Pharmaceutical Co., Ltd.
进行中（未招募）
1 期
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors. - ITCC-004-GEMOXRefractory or relapsing malignant pediatric solid tumors.EUCTR2006-001065-41-GBniversity Hospitals of Leicester NHS Trust, Research and Development Directorate156
进行中（未招募）
不适用
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - ITCC-004-GEMOXrefractory or relapsing malignant pediatric solid tumorsEUCTR2006-001065-41-DEInstitut Gustave Roussy156
进行中（未招募）
不适用
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors.(Etude de phase II de l’association Gemcitabine - Oxaliplatine « GEMOX » chez les patients porteurs d’une tumeur solide maligne réfractaire ou en rechute). - ITCC-004-GEMOXrefractory or relapsing malignant pediatric solid tumors.EUCTR2006-001065-41-NLInstitut Gustave Roussy156